Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,501.65 0.00 0.00%
S&P 500 1,878.61 3.22 0.17%
NASDAQ 4,148.34 21.37 0.52%
Ticker Volume Price Price Delta
STOXX 50 3,189.81 13.84 0.44%
FTSE 100 6,703.00 28.26 0.42%
DAX 9,548.68 4.49 0.05%
Ticker Volume Price Price Delta
NIKKEI 14,404.99 -141.28 -0.97%
TOPIX 1,164.90 -8.91 -0.76%
HANG SENG 22,562.80 53.16 0.24%

LifeVantage to Present at 15th Annual ICR XChange



LifeVantage to Present at 15th Annual ICR XChange

SALT LAKE CITY, Jan. 8, 2013 (GLOBE NEWSWIRE) -- LifeVantage Corporation
(Nasdaq:LFVN), a company dedicated to helping people achieve healthy living
through a combination of a compelling business opportunity and scientifically
validated products, including its patented dietary supplement Protandim®, the
Nrf2 Synergizer®, announced today that Douglas C. Robinson, the Company's
President and Chief Executive Officer, and David Colbert, the Company's Chief
Financial Officer, will be presenting at the 15^th Annual ICR XChange, to be
held January 16-17, 2013, at The Fontainebleau Hotel in Miami Beach, Florida.

The LifeVantage Corporation investor presentation is scheduled for Wednesday,
January 16, 2013, at 8:00 am Eastern Time. The presentation will be webcast
live and archived on the Investor Info portion of the Company's website at
http://investor.lifevantage.com/events.cfm.

About LifeVantage Corporation

LifeVantage (Nasdaq:LFVN), a leader in Nrf2 science and the maker of
Protandim®, the Nrf2 Synergizer® patented dietary supplement, is a science
based nutraceutical company. LifeVantage is dedicated to visionary science
that looks to transform wellness and anti-aging internally and externally with
products that dramatically reduce oxidative stress at the cellular level. The
Company was founded in 2003 and is headquartered in Salt Lake City, UT.

The LifeVantage Corporation logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=11617

CONTACT: Investor Relations Contact:
         Cindy England (801) 432-9036
         Director of Investor Relations
         -or-
         John Mills (310) 954-1105
         Senior Managing Director, ICR, LLC

company logo
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement